Scarica l'app Stockscreener
12.67
0.48%
0.06
Dopo l'orario di chiusura:
12.66
-0.010
-0.08%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Delcath Systems Inc Borsa (DCTH) Ultime notizie
Delcath Systems Awards 30,000 Stock Options to New Employee at $12.04 Per Share - StockTitan
State Street Corp Buys 9,400 Shares of Delcath Systems, Inc. (NASDAQ:DCTH) - Defense World
Delcath Systems, Inc. (NASDAQ:DCTH) Short Interest Update - MarketBeat
Wall Street Analysts Believe Delcath Systems (DCTH) Could Rally 96.84%: Here's is How to Trade - MSN
Delcath Systems raises additional USD 16.3M in funding - Medical Buyer
Delcath Systems announces additional $16.3 million in funding from warrant exercises - MSN
Delcath Systems (NASDAQ: DCTH) Announces Recent Funding and Warrant AmendmentsQueensbury, New York, December 30, 2024 – Delcath Systems, Inc. (NASDAQ: DCTH) recently disclosed important financial developments through an 8-K filing with th - Defense World
Delcath secures $16.3 million from warrant exercises By Investing.com - Investing.com Nigeria
Delcath Systems Secures $16.3 Million in Funding Through Warrant Exercise to Propel Growth in Oncology Treatments - Tandav Media
Delcath secures $16.3 million from warrant exercises - Investing.com India
Delcath Systems Secures $16.3M from Warrant Exercise - TipRanks
Delcath Systems Raises $16.3M Through Warrant Exercise to Advance HEPZATO Melanoma Treatment - StockTitan
3 US Growth Companies To Watch With Up To 32% Insider Ownership - Simply Wall St
(DCTH) Technical Data - Stock Traders Daily
Analysts Expect Breakeven For Delcath Systems, Inc. (NASDAQ:DCTH) Before Long - Yahoo Finance
Does Delcath Systems (NASDAQ:DCTH) Have A Healthy Balance Sheet? - Simply Wall St
Where are the Opportunities in (DCTH) - Stock Traders Daily
Delcath Systems stock soars to 52-week high of $12.99 - Investing.com
Positive Preliminary Results from Delcath Systems’ FOCUS Trial Presented at the 2021 ASCO Annual Meeting - Marketscreener.com
Clear Street initiates Buy on Delcath Systems stock, highlights profitability potential - Investing.com
Thinking about buying stock in Nikola, Delcath Systems, Taysha G - GuruFocus.com
Uveal melanoma Treatment Market: Segmentation Trends, - openPR
When (DCTH) Moves Investors should Listen - Stock Traders Daily
Polar Asset Management Partners Inc. Purchases New Position in Delcath Systems, Inc. (NASDAQ:DCTH) - MarketBeat
Delcath to trial Hepzato drug device combo in colorectal cancer - Yahoo Finance
FDA finishes review of Delcath’s IND application of HEPZATO combo trial - TipRanks
Delcath Secures FDA Clearance for Phase 2 Trial of HEPZATO in Colorectal Cancer - StockTitan
Delcath Systems (NASDAQ:DCTH) jumps 13% this week, taking one-year gains to 330% - Yahoo Finance
Delcath Systems Inc (DCTH) Shares Up 5.61% on Nov 29 - GuruFocus.com
Delcath Systems (NASDAQ:DCTH) spikes 17% this week, taking one-year gains to 301% - Simply Wall St
Objective long/short (DCTH) Report - Stock Traders Daily
DCTH (Delcath Systems) 3-Year FCF Growth Rate : 38.20% (As of Sep. 2024) - GuruFocus.com
Principal Financial Group Inc. Makes New $808,000 Investment in Delcath Systems, Inc. (NASDAQ:DCTH) - MarketBeat
89,447 Shares in Delcath Systems, Inc. (NASDAQ:DCTH) Bought by Principal Financial Group Inc. - Defense World
Delcath Systems Reports Strong Q3 Growth and Expansion - MSN
Delcath Begins Platform Expansion With Two Phase 2 Trials (NASDAQ:DCTH) - Seeking Alpha
Delcath Systems, Inc. (DCTH) Reports Q3 Loss - MSN
Delcath Systems: Q3 Earnings Reveal HEPZATO KIT And CHEMOSAT Growth (NASDAQ:DCTH) - Seeking Alpha
(DCTH) Investment Analysis - Stock Traders Daily
Delcath Systems Stock (NASDAQ:DCTH) Among the Best Multibagger Stock to Buy Heading into 2025 - Insider Monkey
Rosalind Advisors, Inc. Increases Stake in Delcath Systems Inc - GuruFocus.com
10 Best Multibagger Stocks To Buy Heading into 2025 - Insider Monkey
Intrahepatic Cholangiocarcinoma Treatment Market size is expected to grow owing to the launch of emerging therapies by 2034, estimates DelveInsight - Barchart
FY2024 EPS Estimate for Delcath Systems Raised by Analyst - MarketBeat
HC Wainwright Forecasts Weaker Earnings for Delcath Systems - MarketBeat
Uveal melanoma Treatment Market Countermeasures Of Economic - openPR
HC Wainwright Reiterates Buy Rating for Delcath Systems (NASDAQ:DCTH) - MarketBeat
Delcath Systems revenue hits USD 11.2M in Q3 2024, a 44% increase - Medical Buyer
Delcath Systems Third Quarter 2024 Earnings: Beats Expectations - Yahoo Finance
Delcath Systems stock soars to 52-week high of $12 amid robust gains - Investing.com Australia
Delcath Systems Inc (DCTH) Q3 2024 Earnings Call Highlights: Str - GuruFocus.com
Delcath Systems Inc (DCTH) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and ... - Yahoo Finance
Delcath Systems, Inc. (NASDAQ:DCTH) Q3 2024 Earnings Call Transcript - Insider Monkey
0.82%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):